Meelis Lootus
Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group - IEEE
Meelis is the CEO & founder of Tehistark, working with biotechnology and pharmaceutical companies to accelerate clinical trial and regulatory workflows with AI. He was previously director of AI engineering at Sharecare Inc (core team at doc.ai, acquired by Sharecare), where he led teams to deploy cutting edge AI models in production. His team’s focus was on digital biomarkers. He is an expert on clinical trial innovation and sits on the IEEE committee on decentralised clinical trial design and digital biomarkers, where he led development of guidelines and recommendations. He has a PhD in AI applied to digital health from Oxford University, autimating the interpretation of MRI scans
Sessions
-
Wednesday - May 29, 2024 - 16:15
Interpretation and Impact of Real-World Clinical Data
- Strategies for better decision-making
- High-level models and simulations compelled by data will allow elimination of risky trials
- The potential of real world data in clinical research goes past patient identification and patient recruitment
-
Wednesday - May 29, 2024 - 16:45
Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas
Stay Informed
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
follow us
Follow us online to stay up to date about our conferences
For general conference and registration enquires please contact the below email id or fill out the form
info@corvusglobalevents.com
+44 (0) 207 096
0786
Experience the power of community building
Comprehensive Event Listings
Swift Event Registration
Enhanced Networking Opportunities
In-App Chat Feature
Schedule Meetings
Interactive session participation
Real-time event updates and notifications
Feedback and survey tools
Badge Scanning
Robust security and data protection
Continuous Connectivity for long-term professional relationships
